{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T16:38:19Z","timestamp":1794328699172,"version":"4.9.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T00:00:00Z","timestamp":1768262400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"vor","delay-in-days":14,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Medizinische Fakult\u00e4t Mannheim der Universit\u00e4t Heidelberg"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Accurate imaging plays a crucial role for prognostic assessment and treatment allocation in soft tissue sarcoma (STS). Guidelines recommend contrast-enhanced magnetic resonance imaging (MRI) including diffusion-weighted imaging (DWI) for tumor assessment. This study aims to evaluate the extent to which the MRI protocols used in clinical practice align with the sequences specified in the guideline in the diagnostic work-up of sarcoma patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We analyzed a cohort of patients treated at the Sarcoma Center of the University Medical Center Mannheim (UMM). Pretherapeutic MRI protocols were compared with the recommendations of the German sarcoma guideline.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We analyzed 64 MRI examinations of patients with STS of the extremities and trunk, notably 62 performed at external radiology centers and 2 at UMM.<\/jats:p>\n                    <jats:p>A pretherapeutic contrast-enhanced MRI was available in 51 of 64 cases (79.7%), of which 40 referrals explicitly indicated a soft tissue tumor. In 3.1% of the cases, the complete set of guideline-recommended sequences was not performed. At least two of the required sequences were consistently available. The most frequently absent sequences were the T1-weighted sequence without fat saturation acquired before and after contrast administration using identical acquisition parameters (82.8%) and DWI sequences (78.1%).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>MRI protocol selection is primarily guided by the clinical referral question. Our analysis indicates that a substantial proportion of examinations deviated from recommended protocols. Contributing factors may include inaccurate clinical referral questions, limited guideline awareness, reimbursement constraints in outpatient settings, or diagnostic considerations. Standardized imaging represents a key instrument for quality assurance in the diagnosis of STS and forms the foundation for clinical and translational studies. In the future, the recommendations should be re-evaluated and published in a clear, accessible format to ensure broad implementation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12885-026-15569-3","type":"journal-article","created":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T23:44:41Z","timestamp":1768261481000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Evaluation of magnetic resonance imaging parameters and compliance with guidelines in soft tissue sarcomas"],"prefix":"10.1186","volume":"26","author":[{"given":"Madelaine","family":"Hettler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josephine","family":"Kirschstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Ayx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Harbr\u00fccker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franka","family":"Menge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Rei\u00dffelder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Sch\u00f6nberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominik","family":"N\u00f6renberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias F","family":"Froelich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Jakob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,13]]},"reference":[{"key":"15569_CR1","doi-asserted-by":"crossref","unstructured":"Ressing M et al. Strengthening health data on a rare and heterogeneous disease: sarcoma incidence and histological subtypes in Germany. BMC Public Health. 2018;18(1):235.","DOI":"10.1186\/s12889-018-5131-4"},{"issue":"3","key":"15569_CR2","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.ejca.2012.09.011","volume":"49","author":"CA Stiller","year":"2013","unstructured":"Stiller CA, et al. Descriptive epidemiology of sarcomas in europe: report from the RARECARE project. Eur J Cancer. 2013;49(3):684\u201395.","journal-title":"Eur J Cancer"},{"issue":"5","key":"15569_CR3","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1002\/jso.21600","volume":"102","author":"DC Strauss","year":"2010","unstructured":"Strauss DC, et al. The role of core needle biopsy in the diagnosis of suspected soft tissue tumours. J Surg Oncol. 2010;102(5):523\u20139.","journal-title":"J Surg Oncol"},{"key":"15569_CR4","doi-asserted-by":"publisher","first-page":"100215","DOI":"10.1016\/j.eclinm.2019.11.008","volume":"17","author":"D Callegaro","year":"2019","unstructured":"Callegaro D, et al. Development and external validation of a dynamic prognostic nomogram for primary extremity soft tissue sarcoma survivors. EClinicalMedicine. 2019;17:100215.","journal-title":"EClinicalMedicine"},{"issue":"7","key":"15569_CR5","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1097\/PAS.0000000000000867","volume":"41","author":"N Schneider","year":"2017","unstructured":"Schneider N, et al. The adequacy of core biopsy in the assessment of smooth muscle neoplasms of soft tissues: implications for treatment and prognosis. Am J Surg Pathol. 2017;41(7):923\u201331.","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"15569_CR6","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s00256-015-2302-6","volume":"45","author":"PA Gondim Teixeira","year":"2016","unstructured":"Gondim Teixeira PA, et al. Diffusion-weighted magnetic resonance imaging for the initial characterization of non-fatty soft tissue tumors: correlation between T2 signal intensity and ADC values. Skeletal Radiol. 2016;45(2):263\u201371.","journal-title":"Skeletal Radiol"},{"issue":"2","key":"15569_CR7","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1148\/radiol.2332031110","volume":"233","author":"CSP Van Rijswijk","year":"2004","unstructured":"Van Rijswijk CSP, et al. Soft-Tissue tumors: value of static and dynamic gadopentetate Dimeglumine\u2013enhanced MR imaging in prediction of malignancy. Radiology. 2004;233(2):493\u2013502.","journal-title":"Radiology"},{"key":"15569_CR8","unstructured":"S3-Leitlinie, Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft, Deutsche Krebshilfe, AWMF): S3-Leitlinie Adulte Weichgewebesarkome, Langversion 1.1,.2022,\u00a0AWMF- Registernummer: 032\/044OL, 2022. https:\/\/www.leitlinienprogramm-onkologie.de\/leitlinien\/adulte-weichgewebesarkome\/"},{"issue":"11","key":"15569_CR9","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1016\/j.annonc.2021.07.006","volume":"32","author":"A Gronchi","year":"2021","unstructured":"Gronchi A, et al. Soft tissue and visceral sarcomas: ESMO\u2013EURACAN\u2013GENTURIS clinical practice guidelines for diagnosis, treatment and follow-up\u2606. Ann Oncol. 2021;32(11):1348\u201365.","journal-title":"Ann Oncol"},{"issue":"7","key":"15569_CR10","doi-asserted-by":"publisher","first-page":"815","DOI":"10.6004\/jnccn.2022.0035","volume":"20","author":"M Von Mehren","year":"2022","unstructured":"Von Mehren M, et al. Soft tissue Sarcoma, version 2.2022, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2022;20(7):815\u201333.","journal-title":"J Natl Compr Canc Netw"},{"issue":"05","key":"15569_CR11","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1055\/s-0035-1569251","volume":"19","author":"M-A Weber","year":"2015","unstructured":"Weber M-A, et al. Soft tissue tumors in adults: ESSR-Approved guidelines for diagnostic imaging. Semin Musculoskelet Radiol. 2015;19(05):475\u201382.","journal-title":"Semin Musculoskelet Radiol"},{"issue":"7","key":"15569_CR12","doi-asserted-by":"publisher","first-page":"4427","DOI":"10.1007\/s00330-023-10425-5","volume":"34","author":"I-M Noebauer-Huhmann","year":"2023","unstructured":"Noebauer-Huhmann I-M, et al. Soft tissue tumor imaging in adults: European society of musculoskeletal Radiology-Guidelines 2023\u2014overview, and primary local imaging: how and where? Eur Radiol. 2023;34(7):4427\u201337.","journal-title":"Eur Radiol"},{"issue":"2","key":"15569_CR13","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.ejso.2017.11.001","volume":"44","author":"NW Mesko","year":"2018","unstructured":"Mesko NW, et al. Pre-operative evaluation prior to soft tissue sarcoma excision \u2013 Why can\u2019t we get it right? Eur J Surg Oncol. 2018;44(2):243\u201350.","journal-title":"Eur J Surg Oncol"},{"issue":"6","key":"15569_CR14","doi-asserted-by":"publisher","first-page":"3324","DOI":"10.1007\/s00330-024-11242-0","volume":"35","author":"I-M Noebauer-Huhmann","year":"2024","unstructured":"Noebauer-Huhmann I-M, et al. Soft tissue tumor imaging in adults: European society of musculoskeletal Radiology\u2013Guidelines 2024: imaging immediately after neoadjuvant therapy in soft tissue sarcoma, soft tissue tumor surveillance, and the role of interventional radiology. Eur Radiol. 2024;35(6):3324\u201335.","journal-title":"Eur Radiol"},{"issue":"2","key":"15569_CR15","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1002\/jmri.25361","volume":"45","author":"F Del Grande","year":"2017","unstructured":"Del Grande F, et al. Characterization of indeterminate soft tissue masses referred for biopsy: what is the added value of contrast imaging at 3.0 tesla? J Magn Reson Imaging. 2017;45(2):390\u2013400.","journal-title":"J Magn Reson Imaging"},{"issue":"9","key":"15569_CR16","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1016\/S0959-8049(01)00083-1","volume":"37","author":"E Gortzak","year":"2001","unstructured":"Gortzak E, et al. A randomised phase II study on neo-adjuvant chemotherapy for \u2018high-risk\u2019 adult soft-tissue sarcoma. Eur J Cancer. 2001;37(9):1096\u2013103.","journal-title":"Eur J Cancer"},{"issue":"4","key":"15569_CR17","doi-asserted-by":"publisher","first-page":"e0320240","DOI":"10.1371\/journal.pone.0320240","volume":"20","author":"G Zhu","year":"2025","unstructured":"Zhu G, et al. Dynamic contrast-enhanced magnetic resonance imaging parameters combined with diffusion-weighted imaging for discriminating malignant lesions, molecular subtypes, and pathological grades in invasive ductal carcinoma patients. PLoS ONE. 2025;20(4):e0320240.","journal-title":"PLoS ONE"},{"key":"15569_CR18","doi-asserted-by":"crossref","unstructured":"Valenzuela RF et al. Building a pre-surgical multiparametric-MRI-based morphologic, qualitative, semiquantitative, first and high-order radiomic predictive treatment response model for undifferentiated pleomorphic sarcoma to replace RECIST. Cancer Imaging. 2025;25(1).","DOI":"10.1186\/s40644-025-00873-1"},{"issue":"2","key":"15569_CR19","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1007\/s00330-019-06445-9","volume":"30","author":"JH Lee","year":"2020","unstructured":"Lee JH, et al. Soft tissue sarcoma: DWI and DCE-MRI parameters correlate with Ki-67 labeling index. Eur Radiol. 2020;30(2):914\u201324.","journal-title":"Eur Radiol"},{"issue":"3","key":"15569_CR20","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1148\/radiol.2019181659","volume":"291","author":"A Cromb\u00e9","year":"2019","unstructured":"Cromb\u00e9 A, et al. Soft-Tissue sarcomas: assessment of MRI features correlating with histologic grade and patient outcome. Radiology. 2019;291(3):710\u201321.","journal-title":"Radiology"},{"issue":"5","key":"15569_CR21","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.diii.2022.12.001","volume":"104","author":"A Cromb\u00e9","year":"2023","unstructured":"Cromb\u00e9 A, et al. Soft-tissue sarcoma in adults: imaging appearances, pitfalls and diagnostic algorithms. Diagn Interv Imaging. 2023;104(5):207\u201320.","journal-title":"Diagn Interv Imaging"},{"issue":"12","key":"15569_CR22","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1016\/j.acra.2022.03.009","volume":"29","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, et al. Diagnostic performance of dynamic Contrast-Enhanced MRI and 18F-FDG PET\/CT for evaluation of soft tissue tumors and correlation with pathology parameters. Acad Radiol. 2022;29(12):1842\u201351.","journal-title":"Acad Radiol"},{"issue":"7","key":"15569_CR23","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1007\/s00256-024-04598-3","volume":"53","author":"F Shomal Zadeh","year":"2024","unstructured":"Shomal Zadeh F, et al. Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) in differentiation of soft tissue sarcoma from benign lesions: a systematic review of literature. Skeletal Radiol. 2024;53(7):1343\u201357.","journal-title":"Skeletal Radiol"},{"issue":"8","key":"15569_CR24","doi-asserted-by":"publisher","first-page":"4485","DOI":"10.1007\/s00330-018-5845-9","volume":"29","author":"A Chhabra","year":"2019","unstructured":"Chhabra A, et al. Conventional MR and diffusion-weighted imaging of musculoskeletal soft tissue malignancy: correlation with histologic grading. Eur Radiol. 2019;29(8):4485\u201394.","journal-title":"Eur Radiol"},{"key":"15569_CR25","doi-asserted-by":"crossref","unstructured":"Hettler M et al. Comparing apparent diffusion coefficient and FNCLCC grading to improve pretreatment grading of soft tissue Sarcoma-A translational feasibility study on fusion imaging. Cancers (Basel), 2022. 14(17).","DOI":"10.3390\/cancers14174331"},{"issue":"7","key":"15569_CR26","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1016\/j.acra.2021.08.007","volume":"29","author":"P Spinnato","year":"2022","unstructured":"Spinnato P, et al. Soft tissue sarcomas: the role of quantitative MRI in treatment response evaluation. Acad Radiol. 2022;29(7):1065\u201384.","journal-title":"Acad Radiol"},{"key":"15569_CR27","doi-asserted-by":"crossref","unstructured":"Chhabra A, et al. Soft Tissue-RADS: an ACR Work-in-Progress framework for standardized reporting of Soft-Tissue lesions on MRI. American Journal of Roentgenology; 2025.","DOI":"10.2214\/AJR.25.34013"},{"key":"15569_CR28","unstructured":"KBV. Kassen\u00e4rztliche Bundesvereinigung, Einheitlicher Bewertungsma\u00dfstab (EBM), Stand: 3. Quartal 2025. Berlin, 2025 12.09.2025; Available from: https:\/\/www.kbv.de\/documents\/praxis\/abrechnung\/ebm\/2025-3-ebm.pdf"},{"issue":"10","key":"15569_CR29","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1007\/s00117-024-01325-w","volume":"64","author":"J Vosshenrich","year":"2024","unstructured":"Vosshenrich J, Fritz J. Beschleunigte Muskuloskeletale magnetresonanztomographie Mit Deep-Learning-gest\u00fctzter bildrekonstruktion Bei 0,55 T\u20133 T. Die Radiol. 2024;64(10):758\u201365.","journal-title":"Die Radiol"},{"issue":"2","key":"15569_CR30","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1111\/jon.13187","volume":"34","author":"A Estler","year":"2024","unstructured":"Estler A, et al. Deep learning-accelerated image reconstruction in MRI of the orbit to shorten acquisition time and enhance image quality. J Neuroimaging. 2024;34(2):232\u201340.","journal-title":"J Neuroimaging"},{"issue":"5","key":"15569_CR31","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1007\/s10278-019-00185-4","volume":"32","author":"V Venkataraman","year":"2019","unstructured":"Venkataraman V, et al. Implementing Shared, standardized imaging protocols to improve Cross-Enterprise workflow and quality. J Digit Imaging. 2019;32(5):880\u20137.","journal-title":"J Digit Imaging"},{"issue":"1","key":"15569_CR32","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/jmri.26659","volume":"50","author":"S Ahlawat","year":"2019","unstructured":"Ahlawat S, et al. Magnetic resonance imaging biomarkers in musculoskeletal soft tissue tumors: review of conventional features and focus on nonmorphologic imaging. J Magn Reson Imaging. 2019;50(1):11\u201327.","journal-title":"J Magn Reson Imaging"},{"issue":"5","key":"15569_CR33","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1002\/jmri.27954","volume":"55","author":"S Fang","year":"2022","unstructured":"Fang S, et al. An update in imaging evaluation of histopathological grade of soft tissue sarcomas using structural and quantitative imaging and radiomics. J Magn Reson Imaging. 2022;55(5):1357\u201375.","journal-title":"J Magn Reson Imaging"},{"issue":"3","key":"15569_CR34","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1093\/annonc\/mds501","volume":"24","author":"A Gronchi","year":"2013","unstructured":"Gronchi A, et al. Quality of surgery and neoadjuvant combined therapy in the ISG-GEIS trial on soft tissue sarcomas of limbs and trunk wall. Ann Oncol. 2013;24(3):817\u201323.","journal-title":"Ann Oncol"},{"issue":"4","key":"15569_CR35","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1007\/s00330-018-5786-3","volume":"29","author":"MA Yoon","year":"2019","unstructured":"Yoon MA, et al. Added value of diffusion-weighted imaging to conventional MRI for predicting fascial involvement of soft tissue sarcomas. Eur Radiol. 2019;29(4):1863\u201373.","journal-title":"Eur Radiol"},{"issue":"7","key":"15569_CR36","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1093\/annonc\/mdz124","volume":"30","author":"JY Blay","year":"2019","unstructured":"Blay JY, et al. Surgery in reference centers improves survival of sarcoma patients: a nationwide study. Ann Oncol. 2019;30(7):1143\u201353.","journal-title":"Ann Oncol"},{"issue":"11","key":"15569_CR37","doi-asserted-by":"publisher","first-page":"2852","DOI":"10.1093\/annonc\/mdx484","volume":"28","author":"JY Blay","year":"2017","unstructured":"Blay JY, et al. Improved survival using specialized multidisciplinary board in sarcoma patients. Ann Oncol. 2017;28(11):2852\u20139.","journal-title":"Ann Oncol"},{"issue":"06","key":"15569_CR38","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1055\/s-0040-1721464","volume":"24","author":"I-M Noebauer-Huhmann","year":"2020","unstructured":"Noebauer-Huhmann I-M, et al. Soft tissue sarcoma Follow-up imaging: strategies to distinguish Post-treatment changes from recurrence. Semin Musculoskelet Radiol. 2020;24(06):627\u201344.","journal-title":"Semin Musculoskelet Radiol"},{"issue":"4","key":"15569_CR39","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/s11547-023-01613-w","volume":"128","author":"V Zampa","year":"2023","unstructured":"Zampa V, et al. The added value of the visual analysis of DWI in post-surgery follow-up of soft tissue sarcoma of the extremities: do we really need ADC? Radiol Med. 2023;128(4):467\u201379.","journal-title":"Radiol Med"},{"issue":"2","key":"15569_CR40","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1245\/s10434-019-07696-y","volume":"27","author":"ME Kreis","year":"2020","unstructured":"Kreis ME, et al. MRI-Based use of neoadjuvant chemoradiotherapy in rectal carcinoma: surgical quality and histopathological outcome of the OCUM trial. Ann Surg Oncol. 2020;27(2):417\u201327.","journal-title":"Ann Surg Oncol"},{"key":"15569_CR41","unstructured":"S3-Leitlinie, Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft, Deutsche Krebshilfe, AWMF): S3-Leitlinie Kolorektales Karzinom, Langversion 2.1, 2019. AWMF Registrierungsnummer: 021\/007OL. 2019. http:\/\/www.leitlinienprogrammonkologie.de\/leitlinien\/kolorektales-karzinom\/2019."}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-15569-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-15569-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-15569-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T16:38:20Z","timestamp":1781627900000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-026-15569-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,13]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["15569"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-15569-3","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,13]]},"assertion":[{"value":"7 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The approval of the Ethics Committee II of Heidelberg University was granted on 03.08.2023, under the approval number 2023-852. Written informed consent for participation is obtained from all participants. The study was conducted in compliance with the ethical principles of the Declaration of Helsinki and its later amendments.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"128"}}